BEAM vs OMC · rev $63.5M vs rev $17.27B
Beam Therapeutics Inc (BEAM) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
BEAM currently screens at market cap $2.01B. OMC currently screens at market cap $21.75B.
Not investment advice. Open the BEAM and OMC stock pages for the full models.
Not investment advice.